Insights

Reset

ADVI insights

Insights,

What Clinical Information Does CMS Need for Drug Price Negotiations Under the IRA?

Insights,

| Ashis Kumar Das, PhD, MD, MPH - Director

Real-World Effectiveness vs Clinical Trial Efficacy in Medicare

Insights,

| Ashis Kumar Das, PhD, MD, MPH - Director

Why is Medicare Data Central to IRA Negotiations?

Insights,

| Tyler Seville, MPA - Senior Manager

The Unintended Consequences of Drug Pricing Policies on Orphan Drug Development
View All

Case Studies

Case Study: Rare Disease State Policy Engagement

Case Study: Medicare Part D Liability Model 

Case Study: Understanding the Impact of the MFPs for IPAY 2026

Case Study: Strengthening Positioning for IRA Drug Price Negotiation
View All

Events

Events ADVI Health Experts Attending the American Society of Hematology (ASH) Annual Meeting
Events ADVI Health Attending ISPOR Europe 2025
Events ADVI Health Attending AMCP Nexus 2025
Events ADVI Health Experts Attending AVBCC 2025
Events ADVI Health Attending Meeting on the Mesa 2025
Events ADVI Health Attending Cure SMA Annual Conference
View All

News

In The News ADVI Health’s Lindsay Bealor Greenleaf Featured in Pink Sheet
In The News ADVI Health Experts Featured in STAT: Navigating Recent and Upcoming CMS Policy Shifts
In The News Executive Sales and Business Development Leader Joins ADVI Health as Chief Growth Officer
In The News Tara Southwell Shares Insights on the Budget Reconciliation Bill with Pink Sheet
In The News ADVI’s Lindsay Bealor Greenleaf Joins Managed Healthcare Executive’s Webinar on the Current State of Healthcare
In The News Lindsay Bealor Greenleaf Discusses Trump’s Recent Executive Order in Health Payer Specialist
View All

Videos

ADVI Expert Shares Insight on Recent Policy Developments: OBBA, IRA Negotiation, and HRSA

ADVI Expert John Coster Shares Insights from ACCESS Forum 2025: Medicare Drug Pricing

ADVI Experts Lindsay Greenleaf and Alicia Silver Share Insight After ACCESS Forum 2025 Panels

Amanda Speller Shares Insight on ADVI’s Recent Study Analyzing Access to Precision Medicine and Oncology
View All